Impact of smoking on the results of coronary artery bypass surgery;Einfluss des rauchens auf die ergebnisse der koronaren bypasschirurgie

Herz

Volumn 29, Issue 3, 2004, Pages 310-316

  Mortasawi, Amir ^a   Ashraf, Mohammed Nadeem ^b   Grayson, Antony David ^b   Oo, Aung Ye ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Cardiothoracic Centre Liverpool   (Germany)

Author keywords

Coronary artery bypass grafting; Morbidity; Mortality; Risk adjustment; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BODY MASS; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KAPLAN MEIER METHOD; KIDNEY DYSFUNCTION; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SMOKING;

AGED; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2642534531     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-004-2573-5     Document Type: Article

References (45)

1. Anderson EW, Andelman RJ, Strauch JM, et al. Effect of low level carbon monoxide exposure on onset and duration of angina pectoris. Ann Intern Med 1973;79:46-50.
2. Aronow WS, Cassidy J, Vangrow JS, et al. Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation 1974;50:340-7.
3. Ball K, Turner R. Smoking and the heart. Lancet 1974;2:822-6.
4. Branca P, McGaw P, Light R. Factors associated with prolonged mechanical ventilation following coronary artery bypass surgery. Chest 2001;119:537-46.
5. Brooks-Brunn JA. Postoperative atelectasis and pneumonia. Heart Lung 1995;24:94-115.
6. Burns DM. Tobacco-related disease. Semin Oncol Nurs 2003;19:244-9.
7. Chodoff P, Margand PMS, Knowles CL. Short term abstinence from smoking: its place in preoperative preparation. Crit Care Med 1975;3:131-3.
8. Clements JA. Smoking and pulmonary surfactant. N Engl J Med 1972;286:261-2.
9. Comroe JH Jr. The pharmacological actions of nicotine. Ann N Y Acad Sci 1960;90:48-51.
10. Corberand J, Nguyen F, Do AH, et al. Effect of tobacco on the functions of polymorphonuclear leukocytes. Infect Immunol 1979;23:577-81.
11. Corre F, Lellouch J, Schwartz D. Smoking and leukocyte counts. Results of an epidemiological survey. Lancet 1971;2:632-4.
12. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
13. De Bacquer D, De Backer G, Östör E, et al. Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort. Eur J Cardiovasc Prev Rehabil 2003;10:289-95.
14. Djaiani GN, Phillips-Bute B, Blumenthal JA, et al. Chronic exposure to nicotine does not prevent neurocognitive decline after cardiac surgery. J Cardiothorac Vasc Anesth 2003;17:341-5.
15. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation 1999;100:1464-80.
16. Ferguson TB Jr, Hammill BG, Peterson ED, et al. A decade of change - risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999. Ann Thorac Surg 2002;73:480-90.
17. Ferson M, Edwards A, Lind A, et al. Low natural killer cell activity and immunoglobulin levels associated with smoking in human objects. Int J Cancer 1979;23:603-9.
18. Finley TN, Ladman AJ. Low yield of pulmonary surfactant in cigarette smokers. N Engl J Med 1972;286:223-7.
19. Gerrard JW, Cockcroft DW, Mink TJ, et al. Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis 1980;122:577-81.
20. Ingersoll GL, Grippi MA. Preoperative pulmonary status and postoperative extubation outcome of patients undergoing elective cardiac surgery. Heart Lung 1991;20:137-43.
21. John R, Choudhri AF, Weinberg AD, et al. Multicentre review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg 2000;69:30-6.
22. Herlitz J, Haglid M, Albertsson P, et al. Short- and long-term prognosis after coronary artery bypass grafting in relation to smoking habits. Cardiology 1997;88:492-7.
23. Hogg JC. The effect of smoking on airway permeability. Chest 1983;83:1-2.
24. Hosmer D, Lemeshow S. Applied logistic regression. New York: Wiley & Sons, 1989.
25. Hulzebos EHJ, Van Meeteren NLU, De Bie RA, et al. Prediction of postoperative pulmonary complications on the basis of preoperative risk factors in patients who had undergone coronary artery bypass graft surgery. Phys Ther 2003;83:8-16.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:547-81.
27. Kensler CJ, Battista SP. Chemical and physical factors affecting mammalian ciliary activity. Am Rev Respir Dis 1966;93: Suppl:93-102.
28. Martin RR. Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers. Am Rev Respir Dis 1973;107:596-601.
29. Mason GR, Uszler JM, Effros RM, et al. Rapidly reversible alterations on pulmonary epithelial permeability induced by smoking. Chest 1983;83:6-11.
30. Miller LG, Goldstein G, Murphy M, et al. Reversible alterations in immunoregulatory T cells in smoking. Chest 1982;82:526-9.
31. Moller AM, Maaloe R, Pedersen T. Postoperative intensive care admittance: the role of tobacco smoking. Acta Anaesthesiol Scand 2001;45:345-8.
32. Moller AM, Villebro N, Pedersen T, et al. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002;359:114-7.
33. Mukherjee D, Hsu A, Moliterno DJ, et al. Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients ≤ 40 years old. Am J Cardiol 2003;92:1465-7.
34. Myles PS, Iacono GA, Hunt JO, et al. Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: smokers versus nonsmokers. Anesthesiology 2002;97:842-7.
35. Ngaage DL, Martins E, Orkell E, et al. The impact of the duration of mechanical ventilation on the respiratory outcome in smokers undergoing cardiac surgery. Cardiovasc Surg 2002;10:345-50.
36. Pearce AC, Jones RM. Smoking and anesthesia: preoperative abstinence and perioperative morbidity. Anesthesiology 1984;61:576-84.
37. Roth GM, Shick RM. The cardiovascular effects of smoking with special reference to hypertension. Ann N Y Acad Sci 1960;90:308-16.
38. Silberg A. Biorheological matching: mucociliary interaction and epithelial clearance. Biorheology 1983;20:215-22.
39. Spivack SD, Shinozaki T, Albertini JJ, et al. Preoperative prediction of postoperative respiratory outcome: coronary artery bypass grafting. Chest 1996;109:1222-30.
40. Stedman RL. The chemical composition of tobacco and tobacco smoke. Chem Rev 1968;68:153-207.
41. Turino GM. Effect of carbon monoxide on the cardiorespiratory system. Circulation 1981;63:253A-9A.
42. Van Domburg RT, Meeter K, van Berkel DF, et al. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol 2001;37:2009-10.
43. Warner MA, Offord KP, Warner ME, et al. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989;64:609-16.
44. Warren CPW, Holford-Strevens V, Wong C, et al. The relationship between smoking and total immunoglobulin E levels. J Allergy Clin Immunol 1982;69:370-5.
45. Wynne-Jones K, Jackson M, Grotte G, et al. Limitations of the Parsonnet score for measuring risk stratified in the north west of England. Heart 2000;84:71-8.